Skip to main content
. 2022 Jul 14;15(7):100665. doi: 10.1016/j.waojou.2022.100665

Table 4.

Comparison of anaphylaxis treatment in the adults and older adults.

Adults (18–64 years) n (%) Older adults (≥65 years) n (%) pa
Total 887 (91.3) 84 (8.7)
Treatment
Antihistamines (H1 and/or H2) 836 (94.2) 77 (91.7) 0.340
Steroids 810 (91.3) 74 (88.1) 0.323
Epinephrine 252 (28.4) 43 (53.1) <0.001
Epinephrine autoinjector prescription 330 (37.2) 24 (28.6) 0.116
Immunotherapyb 96 (10.8) 2 (2.4) 0.014
a

Chi Square test (data were shown as number and percentages).

b

Venom immunotherapy